Clinical Trial Update: Metformin and Pioglitazone Effects on YKL-40 Concentrations in Type 2 Diabetes Patients [NA]

View source ↗

Summary

This clinical trial update reports on the effects of metformin and pioglitazone on YKL-40 concentrations in adults with Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Actos (Pioglitazone)
• metformin (metformin)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Type 2 Diabetes Mellitus | NA | Status: COMPLETED